According to Carnegie China’s Xue Gong, Chinese biotech firms are now turning their focus to Southeast Asia, eyeing the region’s largely untapped pharmaceutical markets. In light of China-U.S ...

As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...

The Zhejiang Lions edged the Qingdao Eagles ... league in Qingdao, east China's Shandong Province, April 20, 2025. (Xinhua/Li Ziheng) Qingdao took a 2-1 series lead before the game started ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Chinese biotech industry has grown rapidly to become a major hub of research. However, as US-China trade relations continue to deteriorate, Ben Hargreaves asks whether this could stunt ...

That included the sharing of a US client’s intellectual property (IP) that was transferred to China without consent ... contracting with some overseas biotech providers on data security concerns.

AdAlta subsidiary AdCella brings cutting-edge cellular immunotherapies from Asia – particularly China – into Western markets AdCella has backing of SYNthesis BioVentures Fund, which invests in ...